ArticleJAMA ophthalmology2022
Plasma Levels of Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity Study-More Questions Than Answers?-Reply.
M Elizabeth Hartnett et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it